Home
BIOR
BIOR News

Latest Biora Therapeutics Inc. (BIOR) News on July 27, 2024

Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event

GlobeNewswire

9 days ago

Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event

Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024

GlobeNewswire

19 days ago

Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024

BIOR: BT-600 Topline

Zacks Small Cap Research

19 days ago

BIOR: BT-600 Topline

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

GlobeNewswire

a month ago

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024

GlobeNewswire

2 months ago

Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024

Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024

GlobeNewswire

2 months ago

Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024

BIOR: BT-600 Data in June

Zacks Small Cap Research

2 months ago

BIOR: BT-600 Data in June

GuruFocus.com

2 months ago

Biora Therapeutics Inc (BIOR) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

3 months ago

Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update

Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024

GlobeNewswire

3 months ago

Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024

Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600

GlobeNewswire

3 months ago

Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600

Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology

GlobeNewswire

4 months ago

Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology

Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development

GlobeNewswire

4 months ago

Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development

Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

4 months ago

Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Biora Therapeutics Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Biora Therapeutics Full Year 2023 Earnings: Beats Expectations

Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

4 months ago

Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BIOR: Negotiations Accelerating

Zacks Small Cap Research

4 months ago

BIOR: Negotiations Accelerating

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Biora Therapeutics Inc Earnings Call

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire

4 months ago

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

GlobeNewswire

4 months ago

Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset

GlobeNewswire

5 months ago

Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset

Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600

GlobeNewswire

5 months ago

Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600

Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium

GlobeNewswire

6 months ago

Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium

Summit State Bank (NASDAQ:SSBI) Will Pay A Dividend Of $0.12

Simply Wall St.

6 months ago

Summit State Bank (NASDAQ:SSBI) Will Pay A Dividend Of $0.12

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

GlobeNewswire

6 months ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Spectral Submits Application for UKCA Mark Classification

GlobeNewswire

6 months ago

Spectral Submits Application for UKCA Mark Classification

GuruFocus.com

6 months ago

Financial Institutions Inc (FISI) Reports Mixed Results Amidst Challenging Interest Rate Environment

Financial Institutions, Inc. Announces Fourth Quarter and Full Year 2023 Results

GlobeNewswire

6 months ago

Financial Institutions, Inc. Announces Fourth Quarter and Full Year 2023 Results

Unicycive (UNCY) Up on Positive Hyperphosphatemia Study Update

Zacks

6 months ago

Unicycive (UNCY) Up on Positive Hyperphosphatemia Study Update

BAE Systems’ Combat Mission Systems business awards Espey Manufacturing ‘Partner2Win’ gold medallion at its fifth annual ‘Partner2Win’ supplier symposium

GlobeNewswire

6 months ago

BAE Systems’ Combat Mission Systems business awards Espey Manufacturing ‘Partner2Win’ gold medallion at its fifth annual ‘Partner2Win’ supplier symposium

Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.

GlobeNewswire

6 months ago

Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.

CCSC Technology International Holdings Limited Announces Pricing of Initial Public Offering

GlobeNewswire

6 months ago

CCSC Technology International Holdings Limited Announces Pricing of Initial Public Offering

Biora Therapeutics Provides Outlook for 2024

GlobeNewswire

6 months ago

Biora Therapeutics Provides Outlook for 2024

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600

GlobeNewswire

7 months ago

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Business Wire

7 months ago

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Stran & Company Appoints Ian Thomas Wall as Chief Information Officer

GlobeNewswire

7 months ago

Stran & Company Appoints Ian Thomas Wall as Chief Information Officer

Reuters

7 months ago

Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms

Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platform

GlobeNewswire

7 months ago

Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platform

THE MEXICO FUND, INC. ISSUES ITS 2023 ANNUAL REPORT

PR Newswire

7 months ago

THE MEXICO FUND, INC. ISSUES ITS 2023 ANNUAL REPORT

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

GlobeNewswire

7 months ago

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

BIOR: Capitalizing on Progress: BT-600 to Start

Zacks Small Cap Research

7 months ago

BIOR: Capitalizing on Progress: BT-600 to Start

Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platform

GlobeNewswire

7 months ago

Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platform

Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors

GlobeNewswire

7 months ago

Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors

Brainsway Ltd. Sponsored ADR (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

7 months ago

Brainsway Ltd. Sponsored ADR (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why

7 Stock Winners That Are Up 1,000% or More in 2023

InvestorPlace

7 months ago

7 Stock Winners That Are Up 1,000% or More in 2023

Biora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platform

GlobeNewswire

8 months ago

Biora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platform

In spite of recent selling, insiders still control 62% of LuxUrban Hotels Inc. (NASDAQ:LUXH)

Simply Wall St.

8 months ago

In spite of recent selling, insiders still control 62% of LuxUrban Hotels Inc. (NASDAQ:LUXH)

The past three years for Kopin (NASDAQ:KOPN) investors has not been profitable

Simply Wall St.

8 months ago

The past three years for Kopin (NASDAQ:KOPN) investors has not been profitable

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

ACCESSWIRE

8 months ago

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

G1 Therapeutics (NASDAQ:GTHX) adds US$67m to market cap in the past 7 days, though investors from five years ago are still down 90%

Simply Wall St.

8 months ago

G1 Therapeutics (NASDAQ:GTHX) adds US$67m to market cap in the past 7 days, though investors from five years ago are still down 90%

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Business Wire

8 months ago

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Lands End Inc Earnings Call

Lands' End (LE) Q3 2023 Earnings Call Transcript

Motley Fool

8 months ago

Lands' End (LE) Q3 2023 Earnings Call Transcript

Lands' End Inc (LE) Reports Mixed Q3 Fiscal 2023 Results Amidst Strategic Adjustments

GuruFocus.com

8 months ago

Lands' End Inc (LE) Reports Mixed Q3 Fiscal 2023 Results Amidst Strategic Adjustments

Shareholders in Brightcove (NASDAQ:BCOV) are in the red if they invested three years ago

Simply Wall St.

8 months ago

Shareholders in Brightcove (NASDAQ:BCOV) are in the red if they invested three years ago

ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript

LAMF Global Ventures Corp. I Announces First Extension of Deadline to Complete Initial Business Combination

PR Newswire

8 months ago

LAMF Global Ventures Corp. I Announces First Extension of Deadline to Complete Initial Business Combination

GuruFocus.com

9 months ago

Candel Therapeutics Inc (CADL) Reports Q3 2023 Financial Results and Clinical Progress

Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

9 months ago

Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

GrafTech International Ltd. (NYSE:EAF) Analysts Are Way More Bearish Than They Used To Be

Simply Wall St.

9 months ago

GrafTech International Ltd. (NYSE:EAF) Analysts Are Way More Bearish Than They Used To Be

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Perma-Fix Environmental Services Inc Earnings Call

INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript

Perma-Fix Reports 18% Year-Over-Year Increase in Revenue to $21.9 Million for the Third Quarter of 2023

GlobeNewswire

9 months ago

Perma-Fix Reports 18% Year-Over-Year Increase in Revenue to $21.9 Million for the Third Quarter of 2023

Share on Social Networks: